The financing of innovative photonics companies in their different growth phases is a serious problem in Europe. Thats why Photonics21 strives to improve the access to financing for European photonics companies. This includes start-up phase financing and growth financing.
This is an overview of the activities Photonics21 is doing in that field.
Together with the European Commission and the European Investment Bank we are conducting Webmeetings in which different public European calls and products of the EIB and are being introduced. The Webmeetings are scheduled with a length of around 30-60 minutes. It is possible to ask questions at the end of the session and get feedback from the experts.
After the live sessions the videos are available on the Photonics21 YouTube channel.
EUROPEAN PHOTONICS VENTURE FORUM
The European Photonics Venture Forum (EPVF) promotes innovation and investment into the high-tech entrepreneurs from across Europe. This is an extraordinary chance to connect with VCs, entrepreneurs, industry experts and thought leaders to foster new connections, business and investment providing a broad overview of the European photonics ecosystem.
Photonics21 is partnering with TechTour and Actphast 4.0 to conduct the EPVF since several years. The last events have taken place in Eindhoven, Dublin, Barcelona and Munich. As soon as there are further information available on the 2020 and 2021 event we will inform you here.
INPHO VENTURE SUMMIT
Hosted in an exclusive place in Bordeaux, INPHO Venture Summit 2020 is a dedicated and designed event for investors supporting the hardware business. Our focus for c-executive participants is concrete discussions and high-level interaction. No traditional speech, only fire-side chats prepared by experts. Each participant needs to be approved before registration and payment.
This event is supported by Photonics21 and is taking place every two years. In 2020 the event is taking place on October 22 & 23. Find out more and pre-register to the event on the dedicated event webpage.